https://www.selleckchem.com/pr....oducts/ziftomenib.ht
Therapeutic failure and drug resistance are common and have important implications in the poor prognosis of advanced breast cancer. It is necessary to acquire a natural product to overcome the resistance of cancer and increase the sensitivity of drug-resistant cells to anticancer agents. To demonstrate whether the compound Vielanin K (VK) has the potential to increase the sensitivity of MCF-7 and MCF-7/MDR cells to anticancer agents. Cell viability and proliferative capacity were determined by MTT, colony formation and EdU assays. Ap
Like
Comment
Share
